Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for MolPort-000-883-091

    Client Email Product

    MolPort-000-883-091

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    GLOBAL SALES INFORMATION

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    1
    US DMFs Filed

    US DMFs Filed

    1
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    1
    API REF. PRICE (USD / KG)
    43,647

    API Market Place

    2
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    4
    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    2
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    138.00

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    17
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Alembic's Generic Bromfenac Receives Approval in the U.S.
    Alembic's Generic Bromfenac Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214340

    FDA
    07 Nov 2023
    Share Share
    Lupin gets USFDA nod for Bromfenac Ophthalmic Solution
    Lupin gets USFDA nod for Bromfenac Ophthalmic Solution

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-for-bromfenac-ophthalmic-solution/articleshow/102770550.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    16 Aug 2023
    Share Share
    Eugia's Generic Bromfenac Receives Approval in the U.S.
    Eugia's Generic Bromfenac Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212964

    FDA
    11 Jul 2023
    Share Share
    Enforcement Report for Week of February 20, 2019
    Enforcement Report for Week of February 20, 2019

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-for-Week-of-February-20-2019-1550644123.pdf

    FDA
    20 Feb 2019
    Share Share
    Enforcement Report - Week of February 6, 2019
    Enforcement Report - Week of February 6, 2019

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-6-2019-1549474146.pdf

    FDA
    06 Feb 2019
    Share Share
    Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals
    Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals

    https://insight.rpxcorp.com/litigation_documents/13168076

    PATENT LITIGATION
    10 Dec 2018
    Share Share
    Sun Pharma rises with R&D and bets on specialty drugs
    Sun Pharma rises with R&D and bets on specialty drugs

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-rises-with-rd-and-bets-on-specialty-drugs/articleshow/64458050.cms

    DIVYA RAJAGOPAL ECONOMIC TIMES
    05 Jun 2018
    Share Share
    Prolensa®(bromfenac): Senju Pharmaceutical v. Amneal Pharmaceuticals
    Prolensa®(bromfenac): Senju Pharmaceutical v. Amneal Pharmaceuticals

    https://insight.rpxcorp.com/litigation_documents/12870230

    PATENT LITIGATION
    05 Apr 2018
    Share Share
    Perrigo gets tentative approval for generic Prolensa
    Perrigo gets tentative approval for generic Prolensa

    http://www.drugstorenews.com/article/perrigo-gets-tentative-approval-generic-prolensa

    David Salazar DRUG STORE NEWS
    04 Jan 2018
    Share Share
    How Top Indian Drug Makers Like Sun, Glenmark are Building Business in the US
    How Top Indian Drug Makers Like Sun, Glenmark are Building Business in the US

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/how-top-indian-drug-makers-like-sun-pharma-glenmark-are-building-a-brands-business-in-the-us/articleshow/56382828.cms

    Vikas Dandekar ECONOMIC TIMES
    07 Jan 2017
    Share Share
    Sun Pharma Launches First Branded Drug BromSite in US
    Sun Pharma Launches First Branded Drug BromSite in US

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-launches-first-branded-drug-bromsite-in-us/articleshow/55670251.cms

    ECONOMIC TIMES
    29 Nov 2016
    Share Share
    Mayne Pharma USA Recalls Bromfenac Ophthalmic Sol 0.09% due to Lack of Sterility
    Mayne Pharma USA Recalls Bromfenac Ophthalmic Sol 0.09% due to Lack of Sterility

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0585-2016&w=01272016&lang=eng

    FDA
    27 Jan 2016
    Share Share
    Valeant Announces New U.S. Fulfillment Agreements With Walgreens
    Valeant Announces New U.S. Fulfillment Agreements With Walgreens

    http://www.prnewswire.com/news-releases/valeant-announces-new-us-fulfillment-agreements-with-walgreens-plans-to-further-extend-distribution-to-independent-pharmacies-300192840.html

    PR NEWS WIRE
    16 Dec 2015
    Share Share
    Apotex recalls Bromfenac Ophthalmic Sol due to Lack of Assurance of Sterility
    Apotex recalls Bromfenac Ophthalmic Sol due to Lack of Assurance of Sterility

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0009-2016&w=10212015&lang=eng

    FDA
    22 Oct 2015
    Share Share
    Sun Pharma bids to acquire InSite Vision Inc
    Sun Pharma bids to acquire InSite Vision Inc

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-bids-to-acquire-insite-vision-inc/articleshow/48965209.cms

    PTI THE ECONOMIC TIMES
    15 Sep 2015
    Share Share
    Bausch & Lomb, Inc. recalls Bromfenac Ophthalmic Solution, 0.09% due to Lack of Assurance of Sterility
    Bausch & Lomb, Inc. recalls Bromfenac Ophthalmic Solution, 0.09% due to Lack of Assurance of Sterility

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1349-2015&w=08262015&lang=eng

    FDA
    29 Aug 2015
    Share Share
    Apotex Inc., Ongoing Class III recall of Bromfenac Ophthalmic Solution 0.09%, Rx Only. Mfg For: Apotex Corp., Weston, FL, 33326. Available in a) 1.7 mL Bottle, NDC: 60505-0595-5; b) 2 x 1.7 mL Bottles, NDC: 60505-0595-6; c) 2.5 mL Bottles, NDC: 60505-0596-4. because of CGMP Deviations: Product excipient was not re-tested at the appropriate date.
    Apotex Inc., Ongoing Class III recall of Bromfenac Ophthalmic Solution 0.09%, Rx Only. Mfg For: Apotex Corp., Weston, FL, 33326. Available in a) 1.7 mL Bottle, NDC: 60505-0595-5; b) 2 x 1.7 mL Bottles, NDC: 60505-0595-6; c) 2.5 mL Bottles, NDC: 60505-0596-4. because of CGMP Deviations: Product excipient was not re-tested at the appropriate date.

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0487-2015&w=04222015&lang=eng

    FDA
    22 Apr 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search